Literature DB >> 28108264

Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.

Yaqin Zhu1, Bao Wang2, Kai Tao2, Hengli Yang1, Yixiao Wang1, Tian Zhou1, Yilin Yang1, Lijun Yuan1, Xi Liu3, Yunyou Duan4.   

Abstract

INTRODUCTION: This study aims to explain the mechanisms for the formation of sonographic features of Parkinson's disease (PD) using a 6-hydroxydopamine (6-OHDA) rat model of PD. The iron chelator deferiprone (DFP) was used in the PD model rat to examine the relationship between iron and the echo signal.
METHODS: Rat models were created using stereotactic injections of 6-OHDA. DFP was administered intragastrically. Transcranial sonography (TCS) was performed to observe the substantia nigra (SN) echo signal of the brain. Immunofluorescence and iron staining were performed to observe the histological characteristics of the hyperechogenic area. The imaging findings were compared with the histopathological findings.
RESULTS: The PD model rat presented a large area of hyperechogenicity in the SN. Ferric ion accumulation and microglia proliferation occurred in the hyperechogenic area. DFP inhibited dopaminergic (DA) neuron necrosis, ferric ion accumulation and microglia proliferation and reduced the hyperechogenic area of the SN.
CONCLUSIONS: Both iron aggregation and gliosis contribute to the formation of substantia nigra hyperechogenicity (SNH) in PD. DFP exhibits a neuroprotective effect by inhibiting SNH. Iron deposit and the SNH are correlated with DA neuron necrosis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  6-Hydroxydopamine; Deferiprone; Parkinson's disease; Substantia nigra hyperechogenicity; Transcranial sonography

Mesh:

Substances:

Year:  2017        PMID: 28108264     DOI: 10.1016/j.parkreldis.2017.01.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  13 in total

Review 1.  Drug Repurposing in Parkinson's Disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

Review 2.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

Review 3.  Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.

Authors:  Michele Goulart Dos Santos; Lucia Emanueli Schimith; Corinne André-Miral; Ana Luiza Muccillo-Baisch; Bruno Dutra Arbo; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

Review 4.  Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.

Authors:  Yiyan Sun; Xiaohuan Xia; Diksha Basnet; Jialin C Zheng; Jian Huang; Jianhui Liu
Journal:  Front Aging Neurosci       Date:  2022-06-28       Impact factor: 5.702

5.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 6.  Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta-Analysis.

Authors:  Yan-Liang Mei; Jing Yang; Zheng-Rong Wu; Ying Yang; Yu-Ming Xu
Journal:  Parkinsons Dis       Date:  2021-04-30

7.  Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders.

Authors:  Slawomir Michalak; Jolanta Florczak-Wyspiańska; Joanna Rybacka-Mossakowska; Wojciech Ambrosius; Krystyna Osztynowicz; Aleksandra Baszczuk; Wojciech Kozubski; Ewa Wysocka
Journal:  Oxid Med Cell Longev       Date:  2017-09-10       Impact factor: 6.543

8.  Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro.

Authors:  Young J Yauger; Sara Bermudez; Kasey E Moritz; Ethan Glaser; Bogdan Stoica; Kimberly R Byrnes
Journal:  J Neuroinflammation       Date:  2019-02-18       Impact factor: 8.322

9.  Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.

Authors:  Daniel Richter; Aristeidis H Katsanos; Christoph Schroeder; Georgios Tsivgoulis; George P Paraskevas; Thomas Müller; Andrei V Alexandrov; Ralf Gold; Lars Tönges; Christos Krogias
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

10.  Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.

Authors:  Ting Li; Jing Shi; Bin Qin; Dongsheng Fan; Na Liu; Jingnian Ni; Tianqing Zhang; Hufang Zhou; Xiaoqing Xu; Mingqing Wei; Xuekai Zhang; Xiangzhu Wang; Jianping Liu; Yongyan Wang; Jinzhou Tian
Journal:  Neurol Sci       Date:  2019-11-22       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.